{
  "docId": "019de072-1a15-7369-8097-68fb5b1d5017",
  "docSlug": "de0c004f3134112f269aa7aa17f1a1f3",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 39,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The chart shows a stacked bar breakdown of revenue by region (China vs Ex-China) and COVID-19 vaccine sales over 9 quarters.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-1a15-7369-8097-68fb5b1d5017/25",
  "deckHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017",
  "deckJsonHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017.json",
  "deckAnchorHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.52,
        "w": 0.33,
        "x": 0.04,
        "y": 0.33
      },
      "kind": "chart",
      "text": "Revenue breakdown by quarter for China, Ex-China EMs, and COVID-19 vaccine sales",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbcf247a-168a-416c-b0e4-e6c0aaf4067c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.51,
        "y": 0.26
      },
      "kind": "list",
      "text": "Diversified growth across geographies: Oncology $3.2bn (+6%), CVRM $3.8bn (+12%), Respiratory & Immunology $1.7bn (+4%)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3d0c246-d77e-404f-a780-8383064a16d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.82,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. Vaxzevria Total Revenue includes Collaboration Revenue... 2. Growth number calculated excluding revenue of Vaxzevria.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a91c0d8-7b88-4c33-95f8-6e1921e79ada",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.29,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Emerging Markets",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1a5daba-9d55-48c6-8a44-1222d404a36b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.58,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Total revenue $12.3bn (including Vaxzevria revenue)",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3eddd0bd-84de-4c49-990f-ea4239fe613e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "cecb9049-afa4-44be-b2f9-6e26a4146816",
      "evidence": "chart/bar-stacked: Revenue breakdown by quarter for China, Ex-China EMs, and COVID-19 vaccine sales",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 25,
      "from": 11,
      "beatId": "893385a9-ae10-4064-bd1f-048901a7973b",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The financial results and key messages provide satisfaction by showcasing the company's progress.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}